Literature DB >> 20367196

Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference.

Thomas Kung1, Jochen Springer, Wolfram Doehner, Stefan D Anker, Stephan von Haehling.   

Abstract

Cachexia is an illness that may occur in terminal stages of many chronic illnesses including cancer, chronic heart failure, chronic renal failure or chronic obstructive pulmonary disease. Effective treatments are urgently needed in order to improve the patients' quality of life and their survival. We report highlights from the 5th Cachexia Conference held in December 2009 in Barcelona, Spain. Novel therapeutic approaches shown here include melanocortin-4 receptor antagonists, myostatin inhibition, beta-blockers, IL-6 antagonism synthetic ghrelin and vitamin D.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367196     DOI: 10.1517/13543781003724690

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  17 in total

1.  Sarcopenic Obesity Is Associated with Severe Postoperative Complications in Gastric Cancer Patients Undergoing Gastrectomy: a Prospective Study.

Authors:  Wei-Teng Zhang; Ji Lin; Wei-Sheng Chen; Yun-Shi Huang; Rui-Sen Wu; Xiao-Dong Chen; Neng Lou; Chu-Huai Chi; Chang-Yuan Hu; Xian Shen
Journal:  J Gastrointest Surg       Date:  2018-06-25       Impact factor: 3.452

2.  Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.

Authors:  Shlomit Strulov Shachar; Allison M Deal; Marc Weinberg; Kirsten A Nyrop; Grant R Williams; Tomohiro F Nishijima; Julia M Benbow; Hyman B Muss
Journal:  Clin Cancer Res       Date:  2016-08-03       Impact factor: 12.531

Review 3.  Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting.

Authors:  Astrid Breitbart; Mannix Auger-Messier; Jeffery D Molkentin; Joerg Heineke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

Review 4.  Pathophysiology and treatment options for cardiac anorexia.

Authors:  Marat Fudim; Gabriel Wagman; Rebecca Altschul; Evin Yucel; Michelle Bloom; Timothy J Vittorio
Journal:  Curr Heart Fail Rep       Date:  2011-06

Review 5.  Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses.

Authors:  Pranav Periyalwar; Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2012-01-23       Impact factor: 6.126

6.  Selecting for predisposition to cancer cachexia.

Authors:  Ioannis Gioulbasanis; Panagiotis J Vlachostergios; Christos N Papandreou
Journal:  EMBO Mol Med       Date:  2012-04-11       Impact factor: 12.137

Review 7.  A systematic review of the role of vitamin insufficiencies and supplementation in COPD.

Authors:  Ioanna G Tsiligianni; Thys van der Molen
Journal:  Respir Res       Date:  2010-12-06

8.  Cachexia in heart disease: highlights from the ESC 2010.

Authors:  Thomas Kung; Tibor Szabó; Jochen Springer; Wolfram Doehner; Stefan D Anker; Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-02-24       Impact factor: 12.910

9.  Cancer cachexia: mechanisms and clinical implications.

Authors:  Claire L Donohoe; Aoife M Ryan; John V Reynolds
Journal:  Gastroenterol Res Pract       Date:  2011-06-13       Impact factor: 2.260

10.  Finding good biomarkers for sarcopenia.

Authors:  Gesine Scharf; Joerg Heineke
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-08-02       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.